Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;11(1):18-24.
doi: 10.1111/j.1477-2574.2008.00013.x.

Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP)

Affiliations

Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP)

Krishna V Menon et al. HPB (Oxford). 2009 Feb.

Abstract

Background: In a previous study we reported an 85% R1 rate for pancreatic cancer following the use of the rigorous, fully standardized Leeds Pathology Protocol (LEEPP). As this significantly exceeded R1 rates observed by others, we investigated the reproducibility of margin assessment using the LEEPP in a larger, prospective, observational cohort study and correlated clinicopathological data with survival.

Methods: Clinicopathological features, including exact site and multifocality of margin involvement, and survival were collated from a prospective series of 83 pancreatoduodenectomies for pancreatic (n = 27), ampullary (n = 24) and bile duct cancer (n = 32). Data were compared with those of the previous study in which the same pathology protocol, based on axial slicing and extensive tissue sampling from the circumferential margin, had been used.

Results: The R1 rate was high in pancreatic (82%) and bile duct (72%) cancer and significantly lower in ampullary cancer (25%). Margin positivity was often multifocal, the posterior margin being most frequently involved. Margin status correlated with survival in the entire cohort (P = 0.006) and the pancreatic subgroup (P = 0.046). These findings were consistent with observations in our previous study.

Conclusions: Margin involvement in pancreatic cancer is a frequent and prognostically significant finding when specimens are assessed using the LEEPP.

Keywords: cancer; margin; pancreas; resection; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Specimen dissection according to the Leeds Pathology Protocol. Following multicolour-coded inking of the specimen surface, pancreatoduodenectomy specimens are sliced in an axial plane, providing a large number of specimen slices with good visualization of the tumour and its relationship to key anatomical structures and the anterior, posterior and superior mesenteric vein groove surfaces
Figure 2
Figure 2
Survival of patients with pancreatic cancer. The actual survival curve for the 27 patients with pancreatic cancer shows that patients who underwent an R0 resection had a significantly better outcome than those in whom an R1 resection was performed (P = 0.046)

Comment in

References

    1. Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer registry. Gut. 2005;54:385–387. - PMC - PubMed
    1. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91:1410–1427. - PubMed
    1. Matsuno S, Egawa S, Unno M. R0 resection for ductal pancreatic cancer – Japanese experience. Am J Surg. 2007;194:S110–S114.
    1. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess HH, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–594. - PubMed
    1. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margin on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758–768. - PMC - PubMed